SCHEMBL522901

SCHEMBL522901

O=C(O)c1ccc(Sc2ccccc2)cc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.61
APEX1 P27695 1/20 0.61
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
ALOX15 P16050 1/20 0.50
CDC25A P30304 1/20 0.48
CDC25B P30305 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MCL1 Q07820 3/20 0.46
BCL2 P10415 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 1/20 0.45
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
SIRT1 Q96EB6 2/20 0.43
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2363013 0.94 APEX1 (0.67) KDM4EAPEX1ALDH1A1HPGDALOX15
SCHEMBL22336405 0.94 APEX1 (0.67) KDM4EAPEX1ALDH1A1HPGDALOX15
SCHEMBL261343 0.92 KDM4E (0.64) KDM4EAPEX1ALDH1A1ALOX15CDC25A
SCHEMBL29404402 0.92 KDM4E (0.64) KDM4EAPEX1ALDH1A1ALOX15CDC25A
SCHEMBL29439092 0.92 KDM4E (0.64) KDM4EAPEX1ALDH1A1ALOX15CDC25A
SCHEMBL28680854 0.90 KDM4E (0.62) KDM4EAPEX1ALDH1A1ALOX15CDC25A
SCHEMBL11798474 0.88 KDM4E (0.61) KDM4EAPEX1ALDH1A1ALOX15CDC25A
SCHEMBL7536575 0.86 APEX1 (0.79) KDM4EAPEX1ALDH1A1HPGDALOX15
SCHEMBL3196569 0.85 MCL1 (0.62) KDM4EAPEX1ALDH1A1HPGDALOX15
SCHEMBL13627449 0.85 SIRT1 (0.49) KDM4EAPEX1ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0313407-B1 Method for preparing polyimide and composite material thereof MITSUI TOATSU CHEMICALS (JP) 1996-05-08 EP claimed
CN-116854620-B Abnormal phase separation inhibitor for PCBP1 gene encoding protein 徐州医科大学 2024-10-15 CN disclosed
CN-116854620-A Abnormal phase separation inhibitor for PCBP1 gene encoding protein 徐州医科大学 2023-10-10 CN disclosed
CN-107239008-B Image forming apparatus and process cartridge 富士胶片商业创新有限公司 2022-03-11 CN disclosed
US-11229637-B2 Nitrogen-containing heteroaryl compounds and methods of use thereof FIBROGEN, INC. (US) 2022-01-25 US disclosed
US-11229637-B2 Nitrogen-containing heteroaryl compounds and methods of use thereof FIBROGEN, INC. (US) 2022-01-25 US disclosed
US-20210060000-A1 NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF FIBROGEN, INC. 2021-03-04 US disclosed
US-20210060000-A1 NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF FIBROGEN, INC. 2021-03-04 US disclosed
US-10646482-B2 Nitrogen-containing heteroaryl compounds and methods of use thereof FIBROGEN, INC. (US) 2020-05-12 US disclosed
US-10646482-B2 Nitrogen-containing heteroaryl compounds and methods of use thereof FIBROGEN, INC. (US) 2020-05-12 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed
EP-0474501-B1 Aromatic diamine compound, preparation process of same and polyimide prepared from same MITSUI TOATSU CHEMICALS (JP) 1996-02-14 EP disclosed
EP-0367482-B1 Polyimides and process for the preparation thereof MITSUI TOATSU CHEMICALS (JP) 1994-09-21 EP disclosed
US-5322962-A Produce polyimides with high heat and chemical resistance, processability MITSUI TOATSU CHEMICALS, INC. (JP) 1994-06-21 US disclosed
US-5231160-A AROMATIC DIAMINE COMPOUND, PREPARATION PROCESS OF SAME AND POLYIMIDE PREPARED FROM SAME MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1993-07-27 US disclosed
EP-0474501-A1 Aromatic diamine compound, preparation process of same and polyimide prepared from same MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-03-11 EP disclosed
EP-0367482-A1 Polyimides and process for the preparation thereof MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-05-09 EP disclosed
EP-0303598-A1 POLYETHERIMIDE-POLYAMIDE COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 1989-02-22 EP disclosed
WO-1988006170-A1 POLYETHERIMIDE-POLYAMIDE COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 1988-08-25 WO disclosed
US-4490266-A Process for the preparation of liquids of low inflammability and high viscosity index and the use thereof BAYER AKTIENGESELLSCHAFT (DE) 1984-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11229637-B2 Nitrogen-containing heteroaryl compounds and methods of use thereof HIF1AN, HIF1A, EGLN2 KDM4E 1774/4885APEX1 1019/4885ALDH1A1 1476/4885
US-10646482-B2 Nitrogen-containing heteroaryl compounds and methods of use thereof HIF1AN, HIF1A, EGLN2 KDM4E 1774/4885APEX1 1019/4885ALDH1A1 1476/4885
US-20210060000-A1 NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF HIF1AN, EGLN2, HIF1A KDM4E 1814/4885APEX1 716/4885ALDH1A1 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.